Ortho Dermatologics gets FDA nod for Altreno lotion for acne

Press enter to search
Close search
Open Menu

Ortho Dermatologics gets FDA nod for Altreno lotion for acne

By Sandra Levy - 08/29/2018
Ortho Dermatologics has received the green light from the Food and Drug Administration for Altreno (tretinoin 0.05%) lotion.

The product is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older.

Altreno is the first formulation of tretinoin in a lotion, according to the company.

"Today's FDA approval of Altreno builds upon our strong acne portfolio, providing physicians and patients a trusted retinoid in a lotion formulated to enhance the user's experience with the inclusion of moisturizing attributes of hyaluronic acid, glycerin and collagen," Ortho Dermatologics president Bill Humphries said, in a press statement.

"Altreno lotion spreads easily and is quickly absorbed into the skin allowing acne patients to easily incorporate this once-daily treatment into their skin care regimen."

Related Topics